Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17

被引:15
|
作者
Gargis, Amy S. [1 ]
Karlsson, Maria [1 ,2 ]
Paulick, Ashley L. [1 ]
Anderson, Karen F. [1 ]
Adamczyk, Michelle [1 ]
Vlachos, Nicholas [1 ]
Kent, Alyssa G. [1 ]
McAllister, Gillian A. [1 ]
McKay, Susannah L. [1 ]
Halpin, Alison L. [1 ]
Albrecht, Valerie [1 ]
Campbell, Davina [1 ]
Korhonen, Lauren [1 ]
Elkins, Christopher A. [1 ]
Rasheed, J. Kamile [1 ]
Guh, Alice Y. [1 ]
McDonald, L. Clifford [1 ]
Lutgring, Joseph D. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30329 USA
[2] Goldbelt C6 LLC, Chesapeake, VA USA
关键词
Clostridioides difficile; antibiotic resistance; vancomycin; metronidazole; agar dilution; ANTIMICROBIAL SUSCEPTIBILITY; RESISTANCE; INFECTION; CARE; EMERGENCE; EPIDEMIC;
D O I
10.1093/cid/ciac817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reference susceptibility testing revealed that elevated minimum inhibitory concentrations (MICs) to vancomycin and metronidazole were rare among US Clostridioides difficile isolates. Ribotype 027 was associated with increased MICs to several antibiotics including fluoroquinolones and clindamycin. Background Antimicrobial susceptibility testing (AST) is not routinely performed for Clostridioides difficile and data evaluating minimum inhibitory concentrations (MICs) are limited. We performed AST and whole genome sequencing (WGS) for 593 C. difficile isolates collected between 2012 and 2017 through the Centers for Disease Control and Prevention's Emerging Infections Program. Methods MICs to 6 antimicrobial agents (ceftriaxone, clindamycin, meropenem, metronidazole, moxifloxacin, and vancomycin) were determined using the reference agar dilution method according to Clinical and Laboratory Standards Institute guidelines. Whole genome sequencing was performed on all isolates to detect the presence of genes or mutations previously associated with resistance. Results Among all isolates, 98.5% displayed a vancomycin MIC <= 2 mu g/mL and 97.3% displayed a metronidazole MIC <= 2 mu g/mL. Ribotype 027 (RT027) isolates displayed higher vancomycin MICs (MIC50: 2 mu g/mL; MIC90: 2 mu g/mL) than non-RT027 isolates (MIC50: 0.5 mu g/mL; MIC90: 1 mu g/mL) (P < .01). No vanA/B genes were detected. RT027 isolates also showed higher MICs to clindamycin and moxifloxacin and were more likely to harbor associated resistance genes or mutations. Conclusions Elevated MICs to antibiotics used for treatment of C. difficile infection were rare, and there was no increase in MICs over time. The lack of vanA/B genes or mutations consistently associated with elevated vancomycin MICs suggests there are multifactorial mechanisms of resistance. Ongoing surveillance of C. difficile using reference AST and WGS to monitor MIC trends and the presence of antibiotic resistance mechanisms is essential.
引用
收藏
页码:890 / 896
页数:7
相关论文
共 50 条
  • [41] Assessment of Varicella Surveillance and Outbreak Control Practices - United States, 2012
    Lopez, Adriana S.
    Lichtenstein, Meredith
    Schmid, D. Scott
    Bialek, Stephanie
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2014, 63 (36):
  • [42] Active Transportation Surveillance-United States, 1999-2012
    Whitfield, Geoffrey P.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (03) : E1 - E4
  • [43] GENOMIC EPIDEMIOLOGY OF NEISSERIA GONORRHOEAE WITH REDUCED SUSCEPTIBILITY TO CEFIXIME IN THE UNITED STATES
    Grad, Y. H.
    Kirkcaldy, R.
    Trees, D.
    Dordel, J.
    Goldstein, E.
    Weinstock, H.
    Parkhill, J.
    Hanage, W. P.
    Bentley, S.
    Lipsitch, M.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A31 - A31
  • [44] The economic burden of Clostridioides difficile infection in patients with hematological malignancies in the United States: A case-control study
    Duhalde, Lola
    Lurienne, Lise
    Wingen-Heimann, Sebastian M.
    Guillou, Lucien
    Buffet, Renaud
    Bandinelli, Pierre-Alain
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (07): : 813 - 819
  • [45] US-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016
    Thorpe, C. M.
    McDermott, L. A.
    Tran, M. K.
    Chang, J.
    Jenkins, S. G.
    Goldstein, E. J. C.
    Patel, R.
    Forbes, B. A.
    Johnson, S.
    Gerding, D. N.
    Snydman, D. R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (07)
  • [46] Nontuberculous Mycobacteria Antibiotic Susceptibility Testing And Resistance In The United States
    Daniel-Wayman, S.
    Spaulding, A.
    Zelazny, A. M.
    Olivier, K. N.
    Adjemian, J.
    Lai, Y.
    Kadri, S.
    Prevots, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [47] Trends in Pertussis Diagnostic Testing in the United States, 1990 to 2012
    Faulkner, Amanda E.
    Skoff, Tami H.
    Tondella, M. Lucia
    Cohn, Amanda
    Clark, Thomas A.
    Martin, Stacey W.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (01) : 39 - 44
  • [48] ECONOMIC BURDEN ATTRIBUTABLE TO CLOSTRIDIOIDES DIFFICILE INFECTION OUTSIDE THE UNITED STATES: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW
    Bhaila, R.
    Moss, E.
    Vietri, J.
    Heinrich, K.
    VALUE IN HEALTH, 2020, 23 : S145 - S145
  • [49] Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study
    Younas, Mariam
    Royer, Julie
    Weissman, Sharon B.
    Waites, Katie S.
    Dash, Sangita
    Rac, Hana
    Bookstaver, P. Brandon
    Justo, Julie Ann
    Bell, Linda
    Maki, Anton, Jr.
    Al-Hasan, Majdi N.
    INFECTION, 2020, 48 (01) : 129 - 132
  • [50] Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study
    Mariam Younas
    Julie Royer
    Sharon B. Weissman
    Katie S. Waites
    Sangita Dash
    Hana Rac
    P. Brandon Bookstaver
    Julie Ann Justo
    Linda Bell
    Anton Maki
    Majdi N. Al-Hasan
    Infection, 2020, 48 : 129 - 132